Current and recent multi-center trials:
RE-LY Study
Randomized trial comparing the efficacy and safety of a novel anticoagulant (Dabigatran
Etexilate) with conventional warfarin therapy for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sponsored by
Boehringer Ingelheim Pharmaceuticals
RELY-ABLE Study
Long-term monitoring trial (extension) for patients who completed the RE-LY trial. Sponsored by
Boehringer Ingelheim Pharmaceuticals
ST-Segment Deviation Study (ST Detect study)
Trial to evaluate whether naturally
occurring spontaneous coronary events and exercise induced cardiac
ischemia give rise to detectable changes on intracardiac electrogram signals in patients with implantable cardioverter defibrillator (ICDs) who have coronary artery disease. Sponsored by Medtronic Cardiac Rhythm Disease Management
PACE-MI Registry Study
Registry designed to
analyze beta-blocker dose response effect on outcome over two years in
patients discharged from the hospital after a myocardial infarction. It
will also explore gender and minority differences in beta-blocker utilization and outcomes. Sponsored by National Heart, Lung, and Blood Institute (NHLBI)
PROMISE Study
Trial to compare the defibrillation efficacy
between the 50/50% tilt biphasic waveform and the Tuned biphasic
waveform in a single coil active can configuration. Sponsored by St. Jude Medical
EnRhythm® MRI SureScan™ Study
Clinical study to confirm the safety and efficacy in the clinical magnetic resonance imaging (MRI) environment of the investigational EnRhythm® MRI SureScan™ Pacing System. Sponsored by Medtronic Cardiac Rhythm Disease Management